Deborah H. Telman - 01 Aug 2022 Form 3 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
EVP, Corporate Affairs & GC
Signature
/s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Issuer symbol
GILD
Transactions as of
01 Aug 2022
Net transactions value
$0
Form type
3
Filing time
05 Aug 2022, 19:22:05 UTC
Previous filing
27 May 2022
Next filing
23 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GILD Non-qualified Stock Option (Right to Buy) 01 Aug 2022 Common Stock 48,620 $60.75 Direct F2
holding GILD Restricted Stock Unit 01 Aug 2022 Common Stock 24,690 Direct F1, F3
holding GILD Restricted Stock Unit 01 Aug 2022 Common Stock 8,230 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The restricted stock units have a three-year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested.
F4 The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.